Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression - Wikidata - wikimedia - TriplyDB

Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression

Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression

http://www.wikidata.org/entity/Q35097484

about

Breaking Free of Control: How Conventional T Cells Overcome Regulatory T Cell Suppression.Regulation generation: the suppressive functions of human regulatory T cells PIM1 kinase phosphorylates the human transcription factor FOXP3 at serine 422 to negatively regulate its activity under inflammation Loss of estrogen-mediated immunoprotection underlies female gender bias in experimental Crohn's-like ileitis.Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases Increased percentages of T cells producing interleukin-21 in patients with immune thrombocytopenic purpura.Immunologic biomarkers for clinical and therapeutic management of psoriasis.Interleukin-21 promotes germinal center reaction by skewing the follicular regulatory T cell to follicular helper T cell balance in autoimmune BXD2 mice Effects of cystamine on antioxidant activities and regulatory T cells in lupus-prone mice.B cells expressing IFN-γ suppress Treg-cell differentiation and promote autoimmune experimental arthritis.Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance Influenza A virus induces interleukin-27 through cyclooxygenase-2 and protein kinase A signaling Idelalisib and caffeine reduce suppression of T cell responses mediated by activated chronic lymphocytic leukemia cells.Exchange protein directly activated by cAMP modulates regulatory T-cell-mediated immunosuppression pSTAT3: a target biomarker to study the pharmacology of the anti-IL-21R antibody ATR-107 in human whole blood.Impairment of regulatory T-cell function in autoimmune thyroid disease.Obstacles and opportunities for targeting the effector T cell response in type 1 diabetes.Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.Psoriasis patients exhibit impairment of the high potency CCR5(+) T regulatory cell subset.Interleukin 6 regulates psoriasiform inflammation-associated thrombosis.The percentage of FoxP3+Helios+ Treg cells correlates positively with disease activity in systemic lupus erythematosus.Protective effect of cytosolic phospholipase A2 inhibition against inflammation and degeneration by promoting regulatory T cells in rats with experimental autoimmune encephalomyelitis.The Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppression.New directions in the basic and translational biology of interleukin-27.Boosting regulatory T cell function by CD4 stimulation enters the clinic.Functional dynamics of Foxp3⁺ regulatory T cells in mice and humans.Regulatory T cells in systemic lupus erythematosus.Review: Lymphocytes, cytokines, chemokines and the T-helper 1-T-helper 2 balance in canine atopic dermatitis.New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis.Ex-Th17 (Nonclassical Th1) Cells Are Functionally Distinct from Classical Th1 and Th17 Cells and Are Not Constrained by Regulatory T Cells.An alternative mode of CD43 signal transduction activates pro-survival pathways of T lymphocytes.Tetrandrine, an agonist of aryl hydrocarbon receptor, reciprocally modulates the activities of STAT3 and STAT5 to suppress Th17 cell differentiation.TL1A induces TCR independent IL-6 and TNF-α production and growth of PLZF⁺ leukocytes.In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling.IL-7 downregulates IL-7Rα expression in human CD8 T cells by two independent mechanisms.IL-23 signaling in Th17 cells is inhibited by HIV infection and is not restored by HAART: Implications for persistent immune activation.Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus.Mesenteric injection of adipose-derived mesenchymal stem cells relieves experimentally-induced colitis in rats by regulating Th17/Treg cell balance.Transforming growth factor-β1 promotes Treg commitment in nasal polyposis after intranasal steroid treatment.[Regulatory T-cells in systemic lupus erythematosus. IL-2 is decisive for loss of tolerance].

P2860

Q26744624-417BC206-E6FD-4AB4-940F-8C3C6033DA8A Q26823216-6E03E73E-2526-40AB-B7EE-57E8120E9A79 Q28115749-146569CC-4693-47C4-9820-9E14BC637B04 Q30407800-B9D53618-6D00-4CCD-9D32-96115883AFC8 Q30419941-40535A44-C34D-4F03-8BE4-00223AE9C101 Q33412014-3D64AC4E-44D8-46EC-8D41-DF8990116CE3 Q34030644-467456DC-BD0C-4334-8392-BB05FF60F902 Q34098180-A76BF813-BC62-4F8C-8BF7-542868FF79C7 Q34154776-F5AF75AB-5877-4644-9A3C-37499023A328 Q35627016-0CE56996-F106-4273-A559-DC022E03E9F3 Q35770489-DDEEC098-6708-4B62-9EC4-38E5CA32BC30 Q35874404-F3881200-E5E8-47F8-A9CC-72AE3427B734 Q36296595-0766EB2C-3BAB-4A5F-9652-EA8157F8E92A Q36635113-FCB7A297-D235-48EB-8BA0-B6EE2231BA14 Q36710010-28E2879B-A236-4D25-B7D1-928DE4A48171 Q36991276-A8EC4A4D-D33E-4510-964A-5A4282E4CB2B Q36995345-C6EBE14A-5327-4391-9ADD-04B97DCCA5AF Q37247661-453C98AC-3B5F-4010-B79C-42AFACB1BE79 Q37372754-099EEC6E-1F54-4016-84E7-4676DE6A54DD Q37469175-624162E5-29D2-4EFC-8444-80F1701ACC8D Q37475806-CFAE570F-0D4B-4C56-8DB3-E3A3AF73791B Q37694624-BF932E3B-330F-410A-8196-9E2E87AAB42B Q37695311-72BEF5F9-6DC4-4A47-9F6B-4D1D6B1A71EA Q37969347-59B602F5-D46E-48C5-85E2-0DF6531895AF Q38020477-3CFFD0F7-CAE6-4BDB-8222-BE9236AF29B3 Q38202990-82135AA9-B55F-4F2A-92FE-321D2C078D2E Q38265968-0ADE6D58-7D60-49D8-BEC4-CD467D4D91CF Q38390887-F55FDFA9-397D-4084-A970-C61190D99DC6 Q38799600-91A67B95-F1BA-4580-BA81-54F9DF836C89 Q38975415-53C49D4D-6030-40AD-A7D3-CBD5009F5116 Q39411149-E77985D3-A9AC-4372-AF26-736AF85445D4 Q41520528-C4DB6618-9E93-4A46-A282-893DD4164BFD Q41860534-EF1B034D-8086-4DC2-885A-FA02402D2B26 Q44982658-E1E96857-F02B-4F99-98A0-436C2C41E3E0 Q45288811-A1EF3466-5A83-43B6-A166-8B0826DBDA80 Q45406195-E647E68F-7FDD-4CB2-9FDB-19DA718B9445 Q47757131-C9F602DB-9820-4B2C-9B60-200ADEC2A803 Q49961881-9CC50ECF-29B3-4014-9BEE-9D2959DABB98 Q50547687-6C88D5D5-B4CE-4C3D-B7D1-AA4C3DFA5615 Q53148600-970B8B83-AE4F-4B4D-8D1E-5A150B5F9EBF

P2860

Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression

http://www.wikidata.org/entity/Q35097484

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Stat3 phosphorylation mediates ...... regulatory T cell suppression

@ast

Stat3 phosphorylation mediates ...... regulatory T cell suppression

@en

type

label

Stat3 phosphorylation mediates ...... regulatory T cell suppression

@ast

Stat3 phosphorylation mediates ...... regulatory T cell suppression

@en

prefLabel

Stat3 phosphorylation mediates ...... regulatory T cell suppression

@ast

Stat3 phosphorylation mediates ...... regulatory T cell suppression

@en

P1433

Q35097484-AF83EE6F-1AB3-409B-A048-B77BD8B94C9F

P1476

Q35097484-A1B9373A-CEB2-461B-8175-00D10206D5CC

P2093

Q35097484-5D935806-4A74-4B63-B6F7-78D314C54448

Q35097484-8F5970A8-6E4B-417F-A922-902CF7A77044

Q35097484-AEFA171A-8963-482C-9758-72931083C3BB

P2860

Q35097484-0115DFBB-F813-48AF-895D-1410770FCA47

Q35097484-07060909-F9F1-4D11-9F04-BD5F9274DBBE

Q35097484-0C940AE0-E1B8-4071-AE8B-1C06AE8FE5B2

Q35097484-1CCAB471-2E7F-4A5E-96B1-20BB0DB9C213

Q35097484-219695C8-34A6-44AD-AA58-13A88B6A358B

Q35097484-2368EE47-C2A1-4BD0-A3D8-43A83DA89105

Q35097484-2372695F-D6C5-4D2A-A413-68731DA62047

Q35097484-24C0ECD4-0C9B-468A-8B14-70D263AF1B8A

Q35097484-26F520D9-FFD4-445B-BB56-9176139F66C0

Q35097484-4842A964-0841-4E1F-AF92-B6D91F949EDE

P304

Q35097484-0EBE6EDE-2078-4FAE-AC12-103E5466DD07

P31

Q35097484-F6C2F5D1-1E7B-41E1-BFDE-85E32A49ACEC

P356

Q35097484-5840AFAB-E6A8-459A-8D08-F9E51ECCE88F

P407

Q35097484-503210A5-0315-4DD8-BB3B-CC0FF9AB58B2

P433

Q35097484-387A2A98-CB98-4248-9957-52F34B1D4832

P478

Q35097484-CB6A7613-4CD5-49B4-96E6-7D6E451F1015

P50

Q35097484-014036E7-4C7D-4575-BF88-7022CC802FA5

Q35097484-249FB9D7-68D0-465A-95E5-EEEF92A6752B

P577

Q35097484-35A04E55-BA11-4FBD-8A06-F2C187875F28

P5875

Q35097484-CAF20162-52F7-4D71-969A-D548F269AC1A

P698

Q35097484-E28FAFEF-6EFA-4318-9C64-90303CC5E3E4

P921

Q35097484-DA7B9C50-C2CB-435A-8762-55E40BC4BCF6

P932

Q35097484-9EAEE2DB-B183-47C2-B7BB-CBED0E42AD27

P356

JIMMUNOL.1001455

P1433

Journal of Immunology

P1476

Stat3 phosphorylation mediates ...... regulatory T cell suppression

@en

P2093

Alan D Levine

http://www.w3.org/2001/XMLSchema#string

Andrew B Young

http://www.w3.org/2001/XMLSchema#string

Wendy A Goodman

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function

Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain

Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex

The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription

IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells

Box 3-independent signaling mechanisms are involved in leukemia inhibitory factor receptor alpha- and gp130-mediated stimulation of mitogen-activated protein kinase. Evidence for participation of multiple signaling pathways which converge at Ras

Differential activation of acute phase response factor/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. II. Src homology SH2 domains define the specificity of stat factor activation

P304

3336-3345

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1001455

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P50

Thomas S. McCormick

P577

2011-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49823040

http://www.w3.org/2001/XMLSchema#string

P698

21307288

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

3133678

http://www.w3.org/2001/XMLSchema#string